Contact
Please use this form to send email to PR contact of this press release:
Helix BioPharma Corp. Successfully Out-Licenses Late Stage Biphasix Technology
TO:
Please use this form to send email to PR contact of this press release:
Helix BioPharma Corp. Successfully Out-Licenses Late Stage Biphasix Technology
TO: